Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Alcohol-related chronic exocrine pancreatic insufficiency: diagnosis and therapeutic management. A proposal for treatment by the Italian Association for the Study of the Pancreas (AISP) and the Italian Society of Alcohology (SIA).

Pezzilli R, Caputo F, Testino G, Patussi V, Greco G, Macciò L, Rossin MR, Mioni D, Balbinot P, Gandin C, Zanesini F, Frulloni L, Aricò S, Bottaro LC, Pellicano R, Scafato E; Italian Society of Alcohology (SIA).

Minerva Med. 2019 Oct;110(5):425-438. doi: 10.23736/S0026-4806.19.06043-9. Epub 2019 Apr 1.

PMID:
30938130
2.

Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol.

Caputo F, Agabio R, Vignoli T, Patussi V, Fanucchi T, Cimarosti P, Meneguzzi C, Greco G, Rossin R, Parisi M, Mioni D, Arico' S, Palmieri VO, Zavan V, Allosio P, Balbinot P, Amendola MF, Macciò L, Renzetti D, Scafato E, Testino G.

Intern Emerg Med. 2019 Jan;14(1):143-160. doi: 10.1007/s11739-018-1933-8. Epub 2018 Sep 5.

PMID:
30187438
3.

Alcohol use disorder and GABAB receptor gene polymorphisms in an Italian sample: haplotype frequencies, linkage disequilibrium and association studies.

Caputo F, Ciminelli BM, Jodice C, Blasi P, Vignoli T, Cibin M, Zoli G, Malaspina P.

Ann Hum Biol. 2017 Jun;44(4):384-388. doi: 10.1080/03014460.2017.1287307. Epub 2017 Feb 14.

PMID:
28118741
4.

A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.

Caputo F, Vignoli T, Tarli C, Domenicali M, Zoli G, Bernardi M, Addolorato G.

Int J Environ Res Public Health. 2016 Mar 5;13(3). pii: E290. doi: 10.3390/ijerph13030290. Review.

5.

Pharmacological management of alcohol dependence: from mono-therapy to pharmacogenetics and beyond.

Caputo F, Vignoli T, Grignaschi A, Cibin M, Addolorato G, Bernardi M.

Eur Neuropsychopharmacol. 2014 Feb;24(2):181-91. doi: 10.1016/j.euroneuro.2013.10.004. Epub 2013 Oct 18. Review.

PMID:
24182622
6.

Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: a pilot study.

Caputo F, Del Re A, Brambilla R, Grignaschi A, Vignoli T, Vigna-Taglianti F, Addolorato G, Zoli G, Cibin M, Bernardi M.

J Psychopharmacol. 2014 Jan;28(1):23-30. doi: 10.1177/0269881113504015. Epub 2013 Sep 17.

PMID:
24045881
7.

Alcohol use disorders in the elderly: a brief overview from epidemiology to treatment options.

Caputo F, Vignoli T, Leggio L, Addolorato G, Zoli G, Bernardi M.

Exp Gerontol. 2012 Jun;47(6):411-6. doi: 10.1016/j.exger.2012.03.019. Epub 2012 Apr 10. Review.

8.

Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.

Caputo F, Vignoli T, Maremmani I, Bernardi M, Zoli G.

Int J Environ Res Public Health. 2009 Jun;6(6):1917-29. doi: 10.3390/ijerph6061917. Epub 2009 Jun 24. Review.

9.

GABAergic medications for treating alcohol dependence.

Caputo F, Vignoli T, Francini S, Stoppo M, Bernardi M.

J Clin Psychopharmacol. 2007 Oct;27(5):539-40; author reply 540-2. No abstract available.

PMID:
17873704
10.

Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug.

Caputo F, Stoppo M, Vignoli T, Francini S, Lorenzini F, Bernardi M.

J Clin Psychopharmacol. 2007 Aug;27(4):418. No abstract available.

PMID:
17632241
11.

Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.

Caputo F, Addolorato G, Stoppo M, Francini S, Vignoli T, Lorenzini F, Del Re A, Comaschi C, Andreone P, Trevisani F, Bernardi M; Alcohol Treatment Study Group.

Eur Neuropsychopharmacol. 2007 Dec;17(12):781-9. Epub 2007 Jul 3.

PMID:
17611081
12.

Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports.

Caputo F, Vignoli T, Lorenzini F, Ciuffoli E, Del Re A, Stefanini GF, Addolorato G, Trevisani F, Bernardi M; Alcoholism Treatment Study Group.

Clin Neuropharmacol. 2005 Mar-Apr;28(2):87-9.

PMID:
15795552

Supplemental Content

Loading ...
Support Center